{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:50:11Z","timestamp":1783687811652,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA008748"],"award-info":[{"award-number":["P30-CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1\/1\/19 \\u2013 12\/31\/23"],"award-info":[{"award-number":["1\/1\/19 \\u2013 12\/31\/23"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011983","name":"American Radium Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011983","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.clbc.2025.12.007","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:15:40Z","timestamp":1766621740000},"page":"105-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["American Radium Society Appropriate Use Criteria Report on Radiation in the Management of Ductal Carcinoma in Situ (DCIS) of the Breast"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7529-7473","authenticated-orcid":false,"given":"Eleanor","family":"Harris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parima","family":"Daroui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Rewari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Warren Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Novick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Isabelle","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clbc.2025.12.007_bib0001","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.clbc.2025.12.007_bib0002","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/tbj.12889","article-title":"Adjuvant radiotherapy versus observation following lumpectomy in ductal carcinoma in-situ: a meta-analysis of randomized controlled trials","volume":"24","author":"Garg","year":"2018","journal-title":"Breast J"},{"issue":"32","key":"10.1016\/j.clbc.2025.12.007_bib0003","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1200\/JCO.2013.49.5077","article-title":"Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial","volume":"31","author":"Donker","year":"2013","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2025.12.007_bib0004","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(10)70266-7","article-title":"Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\/ANZ DCIS trial","volume":"12","author":"Cuzick","year":"2011","journal-title":"Lancet Oncol"},{"issue":"32","key":"10.1016\/j.clbc.2025.12.007_bib0005","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1200\/JCO.2014.56.2595","article-title":"Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial","volume":"32","author":"Warnberg","year":"2014","journal-title":"J Clin Oncol"},{"issue":"32","key":"10.1016\/j.clbc.2025.12.007_bib0006","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1200\/JCO.21.01083","article-title":"Randomized phase III trial evaluating radiation following surgical excision for good-risk ductal carcinoma in situ: long-term report from NRG Oncology\/RTOG 9804","volume":"39","author":"McCormick","year":"2021","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2025.12.007_bib0007","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41523-024-00622-w","article-title":"Lumpectomy without radiation for ductal carcinoma in situ of the breast: 20-year results from the ECOG-ACRIN E5194 study","volume":"10","author":"Wright","year":"2024","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.clbc.2025.12.007_bib0008","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.clbc.2025.12.007_bib0009","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1287\/mnsc.9.3.458","article-title":"An experimental application of the Delphi method to the use of experts","volume":"9","author":"Dalkey","year":"1963","journal-title":"Manage Sci"},{"issue":"6","key":"10.1016\/j.clbc.2025.12.007_bib0010","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/jnci\/djr027","article-title":"Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS","volume":"103","author":"Wapnir","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2025.12.007_bib0011","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejca.2018.06.027","article-title":"Dodwell DJ; Sloane Project Steering Group (NHS Prospective Study of Screen-Detected Non-invasive Neoplasias). Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project","volume":"101","author":"Thompson","year":"2018","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.clbc.2025.12.007_bib0012","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/SLA.0000000000001454","article-title":"Relationship between margin width and recurrence of ductal carcinoma In situ: analysis of 2996 women treated with breast-conserving surgery for 30 years","volume":"262","author":"Van Zee","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2025.12.007_bib0013","doi-asserted-by":"crossref","first-page":"m1570","DOI":"10.1136\/bmj.m1570","article-title":"Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study","volume":"369","author":"Mannu","year":"2020","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.clbc.2025.12.007_bib0014","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41416-020-01152-5","article-title":"Sloane Project Steering Committee. Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project","volume":"124","author":"Shabaan","year":"2021","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.clbc.2025.12.007_bib0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10549-018-5048-8","article-title":"Time-varying risks of second events following a DCIS diagnosis in the population-based VT DCIS cohort","volume":"174","author":"Sprague","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"10.1016\/j.clbc.2025.12.007_bib0016","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1245\/s10434-015-4740-8","article-title":"Decreasing recurrence rates for ductal carcinoma In situ: analysis of 2996 women treated with breast-conserving surgery over 30 years","volume":"22","author":"Subhedar","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2025.12.007_bib0017","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13014-018-0964-7","article-title":"Role of postoperative radiotherapy in reducing ipsilateral recurrence in DCIS: an observational study of 1048 cases","volume":"13","author":"Corradini","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clbc.2025.12.007_bib0018","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1186\/s12885-015-1904-7","article-title":"Long-term outcomes of ductal carcinoma in situ of the breast: a systematic review, meta-analysis and meta-regression analysis","volume":"15","author":"Stuart","year":"2015","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.clbc.2025.12.007_bib0019","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10549-013-2670-3","article-title":"Disease-free survival by treatment after a DCIS diagnosis in a population-based cohort study","volume":"141","author":"Sprague","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"10350","key":"10.1016\/j.clbc.2025.12.007_bib0020","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0140-6736(22)01246-6","article-title":"Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07\/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study","volume":"400","author":"Chua","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clbc.2025.12.007_bib0021","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.radonc.2015.01.001","article-title":"The role of boost and hypofractionation as adjuvant radiotherapy in patients with DCIS: a meta-analysis of observational studies","volume":"114","author":"Nilsson","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clbc.2025.12.007_bib0022","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.breast.2018.07.007","article-title":"Breast-conserving therapy for primary ductal carcinoma in Situ in The Netherlands: a multi-center study and population-based analysis","volume":"42","author":"Jobsen","year":"2018","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.clbc.2025.12.007_bib0023","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10549-014-3025-4","article-title":"Influence of boost radiotherapy in patients with ductal carcinoma in situ breast cancer: a multicenter, retrospective study in Korea (KROG 11-04)","volume":"146","author":"Kim","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.clbc.2025.12.007_bib0024","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s12094-019-02168-x","article-title":"Role of boost radiotherapy for local control of pure ductal carcinoma in situ after breast-conserving surgery: a multicenter, retrospective study of 622 patients","volume":"22","author":"Cambra","year":"2020","journal-title":"Clin Transl Oncol"},{"issue":"8","key":"10.1016\/j.clbc.2025.12.007_bib0025","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jamaoncol.2016.6948","article-title":"Association of radiotherapy boost for ductal carcinoma In situ with local control after whole-breast radiotherapy","volume":"3","author":"Moran","year":"2017","journal-title":"JAMA Oncol"},{"issue":"11","key":"10.1016\/j.clbc.2025.12.007_bib0026","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2025.12.007_bib0027","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1470-2045(06)70699-4","article-title":"Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial","volume":"7","author":"Owen","year":"2006","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2025.12.007_bib0028","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"issue":"31","key":"10.1016\/j.clbc.2025.12.007_bib0029","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1200\/JCO.20.01363","article-title":"Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma In situ in a randomized phase III trial: the DBCG HYPO trial","volume":"38","author":"Offersen","year":"2020","journal-title":"J Clin Oncol"},{"issue":"10215","key":"10.1016\/j.clbc.2025.12.007_bib0030","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/S0140-6736(19)32515-2","article-title":"External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial","volume":"394","author":"Whelan","year":"2019","journal-title":"Lancet"},{"issue":"10215","key":"10.1016\/j.clbc.2025.12.007_bib0031","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/S0140-6736(19)32514-0","article-title":"Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial","volume":"394","author":"Vicini","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.clbc.2025.12.007_bib0032","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ejca.2014.12.013","article-title":"Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial","volume":"51","author":"Livi","year":"2015","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.clbc.2025.12.007_bib0033","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/0300891618811278","article-title":"External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3 randomized trial","volume":"105","author":"Becherini","year":"2019","journal-title":"Tumori"},{"key":"10.1016\/j.clbc.2025.12.007_bib0034","doi-asserted-by":"crossref","first-page":"232","DOI":"10.7150\/jca.2.232","article-title":"Biological markers in DCIS and risk of breast recurrence: A systematic review","volume":"2","author":"Lari","year":"2011","journal-title":"J Cancer"},{"issue":"10","key":"10.1016\/j.clbc.2025.12.007_bib0035","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jnci\/djt067","article-title":"A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast","volume":"105","author":"Solin","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.clbc.2025.12.007_bib0036","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-015-3464-6","article-title":"A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone","volume":"152","author":"Rakovitch","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.clbc.2025.12.007_bib0037","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw256","article-title":"Multigene expression assay and benefit of radiotherapy after breast conservation in ductal carcinoma in situ","volume":"109","author":"Rakovitch","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.clbc.2025.12.007_bib0038","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10549-018-4693-2","article-title":"Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies","volume":"169","author":"Rakovitch","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2025.12.007_bib0039","doi-asserted-by":"crossref","first-page":"671047","DOI":"10.3389\/fonc.2021.671047","article-title":"Association of the 12-gene breast DCIS score((R)) assay with local recurrence in patients with ductal carcinoma in situ treated on accelerated partial breast radiotherapy protocols","volume":"11","author":"Leonard","year":"2021","journal-title":"Front Oncol"},{"issue":"23","key":"10.1016\/j.clbc.2025.12.007_bib0040","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1158\/1078-0432.CCR-18-0842","article-title":"A biological signature for breast ductal carcinoma In situ to predict radiotherapy benefit and assess recurrence risk","volume":"24","author":"Bremer","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"15","key":"10.1016\/j.clbc.2025.12.007_bib0041","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1158\/1078-0432.CCR-19-1152","article-title":"Validation of a ductal carcinoma In situ biomarker profile for risk of recurrence after breast-conserving surgery with and without radiotherapy","volume":"26","author":"Weinmann","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2025.12.007_bib0042","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.3390\/cancers13236103","article-title":"Prognositc risk assessment and prediction of radiotherapy benefit for women with ductal carvcinoma in situ (DCIS) of the breast in a randomized clinical trial (SweDCIS)","volume":"13","author":"Warnberg","year":"2021","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.clbc.2025.12.007_bib0043","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/jso.23933","article-title":"The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: a prospective clinical utility assessment of the 12-gene DCIS score result","volume":"111","author":"Alvarado","year":"2015","journal-title":"J Surg Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2025.12.007_bib0044","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1245\/s10434-016-5583-7","article-title":"Clinical utility of the 12-gene DCIS score assay: impact on radiotherapy recommendations for patients with ductal carcinoma In situ","volume":"24","author":"Manders","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2025.12.007_bib0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10549-021-06187-7","article-title":"DUCHESS: an evaluation of the ductal carcinoma in situ score for decisions on radiotherapy in patients with low\/intermediate-risk DCIS","volume":"188","author":"Rakovitch","year":"2021","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"10.1016\/j.clbc.2025.12.007_bib0046","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1245\/s10434-021-09903-1","article-title":"The clinical utility of DCISionRT((R)) on radiation therapy decision making in patients with ductal carcinoma In situ following breast-conserving surgery","volume":"28","author":"Shah","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.clbc.2025.12.007_bib0047","doi-asserted-by":"crossref","first-page":"5919","DOI":"10.1245\/s10434-024-15566-5","article-title":"The clinical utility of a 7-gene biosignature on radiation therapy decision making in patients with ductal carcinoma In situ following breast-conserving surgery: an updated analysis of the DCISionRT\u00ae PREDICT study","volume":"31","author":"Shah","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.clbc.2025.12.007_bib0048","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/jama.2024.26698","article-title":"COMET study investigators. Active monitoring with or without endocrine therapy for low-risk ductal carcinoma In situ: the COMET randomized clinical trial","volume":"333","author":"Hwang","year":"2025","journal-title":"JAMA"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820925003532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820925003532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T11:47:51Z","timestamp":1779450471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820925003532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1526820925003532"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2025.12.007","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"American Radium Society Appropriate Use Criteria Report on Radiation in the Management of Ductal Carcinoma in Situ (DCIS) of the Breast","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2025.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}